Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human CEP55 Protein, N-His

Catalog #:   YHH87101 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q53EZ4
Protein length: Gln189-Lys464
Overview

Catalog No.

YHH87101

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Gln189-Lys464

Predicted molecular weight

34.83 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q53EZ4

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Centrosomal protein of 55 kDa, Cep55, C10orf3, CEP55, Up-regulated in colon cancer 6, URCC6

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CEP55 protein
References

Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients., PMID:40504854

Investigating the Genetic Links Between Immune Cell Profiles and Bladder Cancer: A Multidisciplinary Bioinformatics Approach., PMID:40427030

Identification and validation of shared biomarkers and drug repurposing in psoriasis and Crohn's disease: integrating bioinformatics, machine learning, and experimental approaches., PMID:40406126

CEP55 as a prognostic indicator and a predictive marker in oral squamous cell carcinoma., PMID:40386043

A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision., PMID:40306500

UBTD2 protein molecules emerges as a key prognostic protein marker in glioma: Insights from integrated omics and machine learning analysis of GRM7, NCAPG, CEP55, and other biomarkers., PMID:40286967

CEP55, A Promising Prognostic Biomarker for Pancreatic Neuroendocrine Neoplasms, Promotes Tumor Progression Through Activation of PI3K/AKT/mTOR Pathway., PMID:40249668

iMLGAM: Integrated Machine Learning and Genetic Algorithm-driven Multiomics analysis for pan-cancer immunotherapy response prediction., PMID:40236779

NEMO Family of Proteins as Polyubiquitin Receptors: Illustrating Non-Degradative Polyubiquitination's Roles in Health and Disease., PMID:39996775

Mechanism of Centrosomal Protein 55 (CEP55) Loading Into Exosomes., PMID:39976236

Single-cell and machine learning approaches uncover intrinsic immune-evasion genes in the prognosis of hepatocellular carcinoma., PMID:39958919

Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment., PMID:39911278

RNA binding protein ILF3 increases CEP55 mRNA stability to enhance malignant potential of breast cancer cells and suppress ferroptosis., PMID:39871389

An Integrated Framework to Identify Prognostic Biomarkers and Novel Therapeutic Targets in Hepatocellular Carcinoma-Based Disabilities., PMID:39765633

Pan-cancer analysis of oncogenic role of CEP55 and experiment validation in clear cell renal cell carcinoma., PMID:39550427

ALKBH5 activates CEP55 transcription through m6A demethylation in FOXP2 mRNA and expedites cell cycle entry and EMT in ovarian cancer., PMID:39511642

Biallelic missense CEP55 variants cause prenatal MARCH syndrome., PMID:39414989

Exploring common pathogenic association between Epstein Barr virus infection and long-COVID by integrating RNA-Seq and molecular dynamics simulations., PMID:39391317

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification., PMID:39373505

Integrated bioinformatic analysis reveals the gene signatures, epigenetic roles, and regulatory networks in endometriosis., PMID:39306912

Ailanthone suppresses cell proliferation of renal cell carcinoma partially via inhibition of EZH2., PMID:39298003

Identification of Hub Genes in Comorbidity of Psoriasis and Vitiligo Using Bioinformatics Analysis., PMID:39258216

On discovery of novel hub genes for ER+ and TN breast cancer types through RNA seq data analyses and classification models., PMID:39242688

SPI1-mediated transcriptional activation of CEP55 promotes the malignant growth of triple-negative breast cancer and M2 macrophage polarization., PMID:39197215

Centrosomal Protein 55 Regulates Chromosomal Instability in Cancer Cells by Controlling Microtubule Dynamics., PMID:39195269

N6-methyladenosine-mediated LINC01087 promotes lung adenocarcinoma progression by regulating miR-514a-3p to upregulate centrosome protein 55., PMID:39023191

The prognostic value of immune escape-related genes in lung adenocarcinoma., PMID:38988926

CEP55: Implications for Immunotherapy and Survival in Hepatocellular Carcinoma., PMID:38847172

The Features of Shared Genes among Transcriptomes Probed in Atopic Dermatitis, Psoriasis, and Inflammatory Acne: S100A9 Selection as the Target Gene., PMID:38766834

Molecular Pathogenic Mechanisms of IgA Nephropathy Secondary to COVID-19 mRNA Vaccination., PMID:38301615

Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma., PMID:38254188

Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer., PMID:38250876

Identification of potential key genes for colorectal cancer based on bioinformatics analysis., PMID:38134110

Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer., PMID:38097948

Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts., PMID:37980163

The role of midbody-associated mRNAs in regulating abscission., PMID:37922419

CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification., PMID:37887301

Advanced stage, high-grade primary tumor ovarian cancer: a multi-omics dissection and biomarker prediction process., PMID:37828118

SYT7 is a key player in increasing exosome secretion and promoting angiogenesis in non-small-cell lung cancer., PMID:37774826

Upregulation of the key biomarker kinesin family member 20A (KIF20A) is associated with pulmonary artery hypertension., PMID:37703933

Amorphous silica nanoparticles cause abnormal cytokinesis and multinucleation through dysfunction of the centralspindlin complex and microfilaments., PMID:37608338

CEACAM1 as a molecular target in oral cancer., PMID:37589542

Identification of survival-associated biomarkers based on three datasets by bioinformatics analysis in gastric cancer., PMID:37584004

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer., PMID:37484531

Important roles of Hif1a in maternal or adult BPA exposure induced pancreatic injuries., PMID:37460698

UMAD1 contributes to ESCRT-III dynamic subunit turnover during cytokinetic abscission., PMID:37439191

Inhibition mechanism of testis-expressed gene 14 (TEX14) in cytokinetic abscission: Well-tempered metadynamics simulation studies., PMID:37409705

α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration., PMID:37381005

Identification of key biomarkers and related immune cell infiltration in cervical cancer tissue based on bioinformatics analysis., PMID:37344577

Macrophage-derived exosomal miR-342-3p promotes the progression of renal cell carcinoma through the NEDD4L/CEP55 axis., PMID:37305161

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CEP55 Protein, N-His [YHH87101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only